Business Standard

Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit

The company's other income for the quarter rose to Rs 58.5 crore from Rs 1.7 crore

Glenmark Pharmaceuticals
Premium

SI Reporter New Delhi
Shares of Glenmark Pharmaceuticals rose as high as 7 per cent to Rs 508.50 on the BSE on Monday after the company posted an over two-fold increase in consolidated net profit at Rs 254.04 crore for the quarter ended June 2020 (Q1FY21).

The company had reported a net profit of Rs 109.28 crore for the April-June period of 2019-20.

Consolidated revenue stood at Rs 2,344.78 crore for the first quarter, as compared to Rs 2,322.87 crore in the year-ago period, Glenmark Pharmaceuticals said in a regulatory filing. Other income for the quarter rose to Rs 58.5 crore from Rs 1.7 crore.

On the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in